Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hampton, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Celldex Therapeutics, Inc. has filed 1,268 SEC EDGAR filings since 06 Apr 1995

SEC filing history

Showing 276-300 of 814 matching filings.

Per page
25
Current page
12
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-15006

FORM 8-K

Filing date
17 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-257137

FORM S-8

Filing date
16 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-15006

FORM 8-K

Filing date
06 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-15006

DEF 14A

Filing date
27 Apr 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-15006

FORM 8-K

Filing date
29 Mar 2021
Reporting date
29 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-37761

COWEN FINANCIAL PRODUCTS LLC

Filing date
25 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-37761

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37761

SC 13G/A

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37761

SC 13G/A filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37761

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37761

CELLDEX THERAPEUTICS, INC.

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37761

SC 13G/A filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Jan 2021
Reporting date
01 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-15006

FORM 8-K

Filing date
04 Jan 2021
Reporting date
01 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-15006

FORM 8-K

Filing date
06 Nov 2020
Reporting date
06 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .